Stock Recovers from 52-Week Low as Analyst Targets Remain Upbeat After hitting a 52-week low of $2.45, Absci shares have rebounded, supported by strong liquidity and positive analyst ratings. Despite a significant revenue miss, the company’s focus on R&D and new partnerships has extended its cash runway, with analysts maintaining price targets well above current levels.67